Shelton David C 4
4 · Chemours Co · Filed Aug 30, 2021
Insider Transaction Report
Form 4
Shelton David C
GC, Corp. Secretary & SVP
Transactions
- Sale
Common Stock
2021-08-27$35.00/sh−8,689$304,115→ 63,927.398 total - Exercise/Conversion
Common Stock
2021-08-30$18.45/sh+1,065$19,649→ 64,992.398 total - Exercise/Conversion
Common Stock
2021-08-27$18.45/sh+8,689$160,312→ 72,616.398 total - Sale
Common Stock
2021-08-30$35.00/sh−1,065$37,275→ 63,927.398 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-30−1,065→ 9,886 totalExercise: $18.45Exp: 2022-02-03→ Common Stock (1,065 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-27−8,689→ 10,951 totalExercise: $18.45Exp: 2022-02-03→ Common Stock (8,689 underlying)
Holdings
- 71,500(indirect: By Trust)
Common Stock
- 492(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
- [F2]Includes directly owned shares, restricted stock units, and dividend equivalent units.
- [F3]Shares were sold in multiple transactions at prices ranging from $35.00 to $35.01.
- [F4]Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.